MedPath
HSA Approval

TASULOSE PROLONGED-RELEASE FILM-COATED TABLETS 400 mcg

SIN15573P

TASULOSE PROLONGED-RELEASE FILM-COATED TABLETS 400 mcg

TASULOSE PROLONGED-RELEASE FILM-COATED TABLETS 400 mcg

November 1, 2018

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderSANDOZ SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED, EXTENDED RELEASE

ORAL

Medical Information

G04CA02

tamsulosin

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

Lek Pharmaceuticals d.d. (Ljubljana)

Lek Pharmaceuticals d.d. (Lendava) (Primary and Secondary Packager)

Active Ingredients

Tamsulosin hydrochloride

0.4mg

Tamsulosin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TASULOSE PROLONGED-RELEASE FILM-COATED TABLETS 400 mcg - HSA Approval | MedPath